The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Apr. 14, 2017
Applicant:
The J. David Gladstone Institutes, San Francisco, CA (US);
Inventors:
Melanie Ott, Mill Valley, CA (US);
Daniela Boehm, San Francisco, CA (US);
Assignee:
The J. David Gladstone Institutes, San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61K 38/15 (2006.01); A61K 45/06 (2006.01); A61K 31/19 (2006.01); A61K 31/22 (2006.01); A61K 31/365 (2006.01); A61K 31/551 (2006.01); A61K 31/713 (2006.01); A61K 31/167 (2006.01); A61K 31/222 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 31/167 (2013.01); A61K 31/19 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/365 (2013.01); A61K 31/551 (2013.01); A61K 31/713 (2013.01); A61K 38/15 (2013.01); A61K 45/06 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01);
Abstract
The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.